Jupiter Topco LLC Purchases New Holdings in Acadia Healthcare Company, Inc. $ACHC

Key Points

• Jupiter Topco LLC acquired 39,710 shares of Acadia Healthcare during the second quarter, valued at approximately $1.17 million. Several other institutional investors also increased or initiated positions.
• Acadia reported quarterly EPS of $0.38, beating estimates of $0.35, while revenue reached $865.84 million and declined 0.4% year over year. The company issued fiscal 2026 EPS guidance of $1.45–$1.60.
• Analyst sentiment is mixed but leans positive: UBS, TD Cowen, Jefferies and Guggenheim maintain or initiated “Buy” ratings, while the broader consensus remains “Hold” with an average price target of $29.85.

Jupiter Topco LLC purchased a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 39,710 shares of the company's stock, valued at approximately $1,172,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. EverSource Wealth Advisors LLC grew its holdings in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company's stock worth $32,000 after purchasing an additional 497 shares in the last quarter. Wells Fargo & Company MN raised its stake in Acadia Healthcare by 208.9% in the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company's stock valued at $32,000 after purchasing an additional 1,510 shares in the last quarter. Allworth Financial LP bought a new stake in Acadia Healthcare during the second quarter worth about $45,000. Global Retirement Partners LLC acquired a new stake in Acadia Healthcare during the second quarter worth about $68,000. Finally, Caitong International Asset Management Co. Ltd grew its stake in Acadia Healthcare by 4,264.8% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company's stock worth $76,000 after buying an additional 5,203 shares in the last quarter.

Acadia Healthcare Trading Down 0.9%

Shares of ACHC stock opened at $28.13 on Friday. The firm has a market capitalization of $2.62 billion, a P/E ratio of -2.26, a P/E/G ratio of 9.06 and a beta of 0.62. Acadia Healthcare Company, Inc. has a twelve month low of $11.43 and a twelve month high of $35.83. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20. The stock's fifty day simple moving average is $30.70 and its 200 day simple moving average is $26.51.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The firm had revenue of $865.84 million during the quarter, compared to the consensus estimate of $844.19 million. During the same period last year, the company earned $0.83 earnings per share. The business's quarterly revenue was down .4% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, sell-side analysts predict that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. UBS Group boosted their target price on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a "buy" rating in a research report on Thursday, July 9th. Barclays lifted their price objective on shares of Acadia Healthcare from $25.00 to $32.00 and gave the company an "equal weight" rating in a research note on Thursday, July 30th. TD Cowen boosted their price objective on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a "buy" rating in a research report on Tuesday, July 14th. Jefferies Financial Group raised Acadia Healthcare from a "hold" rating to a "buy" rating and raised their target price for the company from $24.50 to $30.00 in a report on Wednesday, June 3rd. Finally, Guggenheim lifted their price target on Acadia Healthcare from $38.00 to $39.00 and gave the company a "buy" rating in a research note on Thursday, July 30th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Acadia Healthcare presently has a consensus rating of "Hold" and an average target price of $29.85.

About Acadia Healthcare

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source